Steven Cohen

Point72

Steven Cohen is a prominent investor and the founder of Point72 Asset Management, an American hedge fund established in 2014 after his previous firm, S.A.C. Capital Advisors, faced legal challenges. Cohen is known for his aggressive trading strategies and has built a reputation for his ability to generate significant returns through both long and short positions in various sectors. Under his leadership, Point72 reopened to outside investors in 2018, marking a new chapter in the firm’s history and investment philosophy. Point72 Asset Management employs a multi-strategy approach, focusing on fundamental analysis and quantitative methods to identify investment opportunities across various asset classes. The firm has a diverse portfolio, with notable investments in technology and healthcare sectors, reflecting Cohen's belief in the potential for innovation and growth in these areas. The firm’s operations are based in Stamford, Connecticut, and it has become known for its rigorous research and disciplined investment process. Recent disclosures from Point72 reveal a pattern of position reductions and increases, with a notable focus on the SPDR S&P 500 ETF Trust (SPY) and other major stocks such as Microsoft Corp (MSFT) and Taiwan Semiconductor Manufacturing Company Limited (TSM). As of May 15, 2026, the firm reported a significant trim of approximately $1.28 billion in SPY, highlighting its active management style. The disclosed record includes 200 filings, with 74 increases and 103 reductions, indicating a dynamic approach to portfolio management.

Latest Holdings

HoldingReported ValueWeightSharesLast PriceEst. ValueReturn
Lantheus Holdings, Inc.LNTH · Q1 2026$74M0.1%979.3k$105.11$103M+38.6%
21874A11421874A114 · Q1 2026$74M0.1%8.5M------
Rhythm Pharmaceuticals, Inc.RYTM · Q1 2026$74M0.1%846.8k$102.66$87M+18%
Crane CoCR · Q1 2026$74M0.1%429.8k$218.84$94M+28%
Braze, Inc.BRZE · Q1 2026$73M0.1%3.1M$26.21$82M+11%
BioMarin Pharmaceutical Inc.BMRN · Q1 2026$73M0.1%1.3M$58.92$77M+4.3%
iRhythm Technologies, Inc.IRTC · Q1 2026$73M0.1%621.1k$107.67$67M-8.77%
594972AS0594972AS0 · Q1 2026$73M0.1%87.5M------
30034WAD830034WAD8 · Q1 2026$73M0.1%54.1M------
Altria Group IncMO · Q1 2026$73M0.1%1.1M$74.20$82M+12.4%
IDEXX Laboratories IncIDXX · Q1 2026$73M0.1%129.3k$539.47$70M-3.99%
Cboe Global Markets, Inc.CBOE · Q1 2026$73M0.1%258.1k$284.86$74M+1.35%
Global X - Silver Miners ETFSIL · Q1 2026$72M0.1%804.3k$71.91$58M-20.2%
Viper Energy, Inc. - Class A Common StockVNOM · Q1 2026$72M0.1%1.5M$44.78$69M-4.71%
AST SpaceMobile, Inc.ASTS · Q1 2026$72M0.1%870.4k$63.34$55M-23.6%
Abivax S.A.ABVX · Q1 2026$72M0.1%647.2k$129.73$84M+16.5%
92189F67692189F676 · Q1 2026$72M0.1%187.6k------
Axsome Therapeutics, Inc.AXSM · Q1 2026$72M0.1%424.8k$224.71$95M+32.9%
Union Pacific CorporationUNP · Q1 2026$72M0.1%294.8k$301.27$89M+24.2%
PagSeguro Digital Ltd. Class A Common SharesPAGS · Q1 2026$71M0.1%7.1M$9.15$65M-8.68%
Bath & Body Works IncBBWI · Q1 2026$71M0.1%3.8M$21.12$81M+13.1%
Suncor Energy IncSU · Q1 2026$71M0.1%1.1M$62.81$68M-4.89%
The Allstate CorporationALL · Q1 2026$71M0.1%340.5k$253.58$86M+22.3%
04351PAD304351PAD3 · Q1 2026$70M0.1%47.8M------
Legend Biotech CorporationLEGN · Q1 2026$70M0.1%3.9M$22.71$88M+25.5%
International Business Machines CorpIBM · Q1 2026$70M0.1%289.9k$210.62$61M-13.1%
Nasdaq, Inc.NDAQ · Q1 2026$70M0.1%823.7k$91.85$76M+8.2%
Baker Hughes CompanyBKR · Q1 2026$70M0.1%1.1M$55.60$64M-8.93%
Etsy IncETSY · Q1 2026$70M0.1%1.4M$80.91$113M+61.9%
Stellantis NVSTLA · Q1 2026$70M0.1%9.8M$5.75$57M-18.9%
Dynatrace, Inc.DT · Q1 2026$70M0.1%1.9M$40.65$77M+9.92%
TJX Companies, Inc. (The) Common StockTJX · Q1 2026$70M0.1%435.7k$155.00$68M-2.94%
Labcorp Holdings Inc.LH · Q1 2026$70M0.1%260.6k$279.61$73M+4.8%
KS Trust KS CSI China Internet ETFKWEB · Q1 2026$69M0.1%2.4M$26.21$64M-7.83%
Element Solutions Inc. (ESI)ESI · Q1 2026$69M0.1%2M$37.63$77M+10.2%
Guardant Health, Inc.GH · Q1 2026$69M0.1%750.8k$149.75$112M+62.1%
BlackRock, Inc.BLK · Q1 2026$69M0.1%72.1k$1,063.03$77M+10.5%
AXIS Capital Holdings LtdAXS · Q1 2026$69M0.1%680.8k$113.62$77M+12%
Jazz Pharmaceuticals plcJAZZ · Q1 2026$69M0.1%364.4k$242.18$88M+28.1%
M2029K104M2029K104 · Q1 2026$69M0.1%1.9M------
Supernus Pharmaceuticals, Inc. - Common StockSUPN · Q1 2026$68M0.1%1.3M$48.21$64M-6.73%
Reinsurance Group of America, IncorporatedRGA · Q1 2026$68M0.1%333.5k$234.23$78M+14.7%
DTE Energy CompanyDTE · Q1 2026$67M0.1%460.9k$148.91$69M+1.84%
Repligen Corporation - Common StockRGEN · Q1 2026$67M0.1%569.5k$137.60$78M+16.8%
GDS Holdings LimitedGDS · Q1 2026$67M0.1%1.7M$32.55$54M-19.2%
TeraWulf Inc.WULF · Q1 2026$67M0.1%4.6M$20.05$93M+38.9%
Five Below IncFIVE · Q1 2026$67M0.1%292.2k$201.31$59M-11.9%
Bristol-Myers Squibb CompanyBMY · Q1 2026$67M0.1%1.1M$60.85$67M+0.32%
Berkshire Hathaway Inc.BRK-B · Q1 2026$66M0.1%138.6k$493.12$68M+2.9%
Shopify Inc Class A subordinate voting sharesSHOP · Q1 2026$66M0.1%559.1k$124.25$69M+4.75%
Showing 251-300 of 2,425